Pharmaceuticals, Biotechnology and Life Sciences
— FDA sets PDUFA date of July 17, 2021 — SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) announced today that the Biologics…
— FDA sets PDUFA date of July 17, 2021 — SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) announced today that the Biologics…
— FDA sets PDUFA date of July 17, 2021 — SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) announced today that the Biologics…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the…
A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. Based on…
A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. Based on…